Molecular analyzer and reagents
Ended Awarded Last action
- Contract number
- W81K0222F0099
- Awardee
-
Gen-Probe Incorporated UEI QNXWLAJDL4J3
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $543,750
Award facts
- Opportunity
-
- Nucleic acid AMP testing (naat) Pre-Solicitation · W81K0220Q0143 · Posted Jun 1, 2020
- Contract value 100% obligated
- $543,750.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- LEWIS MCCHORD, WA 98431, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $543,750 | |
| Original award | $0 |
About this award
Gen-Probe Incorporated, through its division Gen-Probe Sales & Service, Inc., has been awarded a $543,750 firm fixed price delivery order contract by the Defense Health Agency to provide molecular analyzer systems, reagents, and associated supplies and services. Performance will occur at Madigan Army Medical Center in Washington through September 30, 2023. This delivery order was issued against an existing Indefinite Delivery Contract held by Gen-Probe, but details of the parent vehicle were not disclosed. As a leading provider of molecular diagnostics technologies and assays, Gen-Probe will likely deliver its PANTHER FUSION systems along with APTIMA combo tests for sexually transmitted infections and other reagents to support the medical testing needs of DHA beneficiaries at Madigan through this award. No set aside designation was specified.
Quick answers
Who was awarded contract W81K0222F0099?
W81K0222F0099 was awarded to Gen-Probe Incorporated by Medical Command (Department of the Army) on October 1, 2022.
How much is contract W81K0222F0099 worth?
The government has obligated $543,750 on W81K0222F0099.
Which agency awarded contract W81K0222F0099?
Medical Command (Department of the Army) awarded W81K0222F0099, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0222F0099 an order under another contract?
Yes. W81K0222F0099 is a delivery order under W81K0220D0015, an indefinite delivery contract.
Was contract W81K0222F0099 competed?
The extent of competition for W81K0222F0099 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award